Leelyn Smith, LLC Edwards Lifesciences Corp Transaction History

Leelyn Smith, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $11,132 - $14,252	163 Added 30.13%	704 $52,000
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $31,135 - $40,555	-378 Reduced 41.13%	541 $45,000
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $13,764 - $17,325	-135 Reduced 12.81%	919 $108,000
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $5,318 - $6,534	-50 Reduced 4.53%	1,054 $137,000
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $14,921 - $17,798	-145 Reduced 11.61%	1,104 $125,000
Q2 2021 Aug 31, 2021	SELL	$83.84 - $104.76 $3,353 - $4,190	-40 Reduced 3.1%	1,249 $129,000
Q4 2020 Jan 15, 2021	SELL	$71.69 - $91.23 $21,148 - $26,912	-295 Reduced 18.62%	1,289 $118,000
Q2 2020 Aug 06, 2020	BUY	$57.54 - $76.95 $60,762 - $81,259	1,056 Added 200.0%	1,584 $109,000
Q1 2020 May 06, 2020	BUY	$52.41 - $81.0 $24,685 - $38,151	471 Added 826.32%	528 $100,000
Q4 2019 Feb 06, 2020	BUY	$71.7 - $82.09 $4,086 - $4,679	57 New	57 $13,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Leelyn Smith, LLC, based on Form 13F filings with the SEC.

Stay updated on Leelyn Smith, LLC with notifications on news.